Medicines Co (NASDAQ:MDCO)

36.81
Delayed Data
As of 4:00pm ET
 -0.09 / -0.24%
Today’s Change
24.45
Today|||52-Week Range
43.79
+34.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$2.3B

Company Description

The Medicines Co. operates as a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ.

Contact Information

The Medicines Co.
8 Sylvan Way
Parsippany New Jersey 07054-3801
P:(973) 290-6000
Investor Relations:
(973) 290-6122

Employees

Shareholders

Other institutional69.09%
Mutual fund holders63.89%
Individual stakeholders15.25%

Top Executives

Clive A. MeanwellChief Executive Officer & Director
Christopher VisioliChief Financial Officer & Treasurer
Stephanie PlentEVP & Head-Global Health Economics
Stephen M. RodinSecretary, Executive VP & General Counsel
Christopher T. CoxChief Corporate Development Officer & EVP